Document is current
Any future updates will be listed below
-
Authors
Grover, Natalie S. https://orcid.org/0000-0002-1346-3157
Annunzio, Kaitlin
Watkins, Marcus
Torka, Pallawi https://orcid.org/0000-0002-1681-5883
Karmali, Reem https://orcid.org/0000-0003-0984-4376
Anampa-Guzmán, Andrea https://orcid.org/0000-0002-4292-1137
Oh, Timothy S.
Reves, Heather
Tavakkoli, Montreh
Hansinger, Emily
Christian, Beth
Thomas, Colin
Barta, Stefan K. https://orcid.org/0000-0002-3280-5271
Geethakumari, Praveen Ramakrishnan
Bartlett, Nancy L.
Shouse, Geoffrey
Olszewski, Adam J. https://orcid.org/0000-0002-6472-6658
Epperla, Narendranath https://orcid.org/0000-0002-8216-3457
- License Information
-
More Information
Article History
Received: 30 July 2024
Revised: 1 October 2024
Accepted: 7 October 2024
First Online: 18 October 2024
Competing interests
: NSG: Research funding: Tessa Therapeutics, Cabaletta, BMS, Regeneron. Honoraria/consulting/ad boards for ADC Therapeutics, Genentech, Kite, Novartis, Ono Pharma, BMS, Regeneron, Janssen, Caribou, and Seagen. PT: Honoraria/consulting/ad boards for TG Therapeutics, ADC Therapeutics, Genentech, GenMab and Lilly USA. RK: Advisory Board: BMS, Miltenyi, Abbvie, Genmab, Lilly USA, Genentech/Roche; Grants/Research Support: BMS. Speakers Bureau: AstraZeneca, BeiGene, Morphosys/Incyte BC: Research funding: Genentech, Acerta, Triphase, MorphoSys, SeaGen, Millenium, Bristol-Myers Squibb, F Hoffman-La Roche; Advisory Board: Genentech, ADC Therapeutics SKB: Honoraria: Acrotech, Affimed, Daiichi Sankyo, Kyowa Kirin, Janssen, Seagen PRG: PRG: Consultancy services: Kite/Gilead Pharma, Bristol Myers Squibb (BMS). Advisory board: Pharmacyclics LLC, ADC Therapeutics, Cellectar Biosciences, Ono Pharma, CRISPR therapeutics, IPSEN Biopharma, and Regeneron Pharmaceuticals NLB: Research funding: ADC Therapeutics, Autolus, BMS, Celgene, Forty Seven, Genentech, Immune Design, Janssen, Merck, Millennium, Pharmacyclics, Affirmed Therapeutics, Dynavax, Gilead, MedImmune, Novartis; Consulting/Ad board: Kite Pharma, Pfizer, ADC Therapeutics, Roche/Genentech, Seattle Genetics, BTG, Acerta AJO: Genmab; Precision Bio; Adaptive Biotechnologies; Celldex; Acrotech Biopharma; Schrodinger; TG Therapeutics; Genentech. NE: Research funding: Beigene, Lilly, and Incyte; Speakers Bureau for Beigene and Genentech, Ad boards for ADC Therapeutics, Lilly, and Ipsen; Honorarium from Novartis.
